Cargando…

Analysis of the rs10046 Polymorphism of Aromatase (CYP19) in Premenopausal Onset of Human Breast Cancer

The CYP19 gene encodes aromatase, an enzyme catalyzing the conversion of androgens to estrogens. Studies analyzing associations between single nucleotide polymorphisms in CYP19 and breast cancer risk have shown inconsistent results. The rs10046 polymorphism is located in the 3′ untranslated region o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zins, Karin, Mogg, Maurice, Schneeberger, Christian, Abraham, Dietmar, Schreiber, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907833/ https://www.ncbi.nlm.nih.gov/pubmed/24402127 http://dx.doi.org/10.3390/ijms15010712

Ejemplares similares

Associations between Aromatase CYP19 rs10046 Polymorphism and Breast Cancer Risk: From a Case-Control to a Meta-Analysis of 20,098 Subjects
por: Pineda, Begoña, et al.
Publicado: (2013)

Association of the rs1346044 Polymorphism of the Werner Syndrome Gene RECQL2 with Increased Risk and Premature Onset of Breast Cancer
por: Zins, Karin, et al.
Publicado: (2015)

Association of the Telomerase Reverse Transcriptase rs10069690 Polymorphism with the Risk, Age at Onset and Prognosis of Triple Negative Breast Cancer
por: Zins, Karin, et al.
Publicado: (2023)

Association of the Estrogen Receptor 1 Polymorphisms rs2046210 and rs9383590 with the Risk, Age at Onset and Prognosis of Breast Cancer
por: Miedl, Heidi, et al.
Publicado: (2023)

Genetic variants of CYP19 (aromatase) and breast cancer risk
por: Nedelcheva Kristensen, V, et al.
Publicado: (2000)

Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes
por: Zins, Karin, et al.
Publicado: (2018)

Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
por: Mao, Jun J, et al.
Publicado: (2011)

Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer
por: Colomer, R, et al.
Publicado: (2005)

Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor
por: Jordan, Jennifer H, et al.
Publicado: (2021)

Simple tandem repeat (TTTA)(n )polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women
por: Okobia, Michael N, et al.
Publicado: (2006)

Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis
por: Artigalás, Osvaldo, et al.
Publicado: (2015)

Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer
por: Friesenhengst, Andrea, et al.
Publicado: (2018)

Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk
por: Siegelmann-Danieli, N, et al.
Publicado: (1999)

Cotargeting of CYP-19 (aromatase) and emerging, pivotal signalling pathways in metastatic breast cancer
por: Daldorff, Stine, et al.
Publicado: (2017)

Prophylactic oophorectomy and aromatase inhibitors for premenopausal deep angiomyxoma: A case report and literature review
por: Tonai, Nobutomo, et al.
Publicado: (2022)

Polymorphisms in Phase I (CYP450) Genes CYP1A1 (rs4646421), CYP1B1 (rs1056836), CYP19A1 (rs749292) and CYP2C8 (rs1058930) and Their Relation to Risk of Breast Cancer: A Case-Control Study in Mazandaran Province in North of Iran
por: Golmohammadzadeh, Golpar, et al.
Publicado: (2019)

Association of low penetrance vitamin D receptor Tru9I (rs757343) gene polymorphism with risk of premenopausal breast cancer
por: Iqbal, Mehir un Nisa, et al.
Publicado: (2018)

TP53 rs1042522 polymorphism and early-onset breast cancer
por: Icen-Taskin, Irmak, et al.
Publicado: (2020)

CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case–control study
por: Verla-Tebit, Emaculate, et al.
Publicado: (2005)

Comment on: Kadomoto, S. et al. “Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis” Cancers 2020, 12, 89
por: Zins, Karin, et al.
Publicado: (2020)

A Polymorphism at the 3′-UTR Region of the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor, Anastrozole, in Metastatic Breast Carcinoma
por: Liu, Lei, et al.
Publicado: (2013)

Polymorphisms CYP2R1 rs10766197 and CYP27B1 rs10877012 in Multiple Sclerosis: A Case-Control Study
por: Martinez-Hernandez, A., et al.
Publicado: (2021)

Association between ESR1 rs2234693 single nucleotide polymorphism and uterine fibroids in Taiwanese premenopausal and postmenopausal women
por: Tyan, Yeu-Sheng, et al.
Publicado: (2023)

Prognostic Value of CYP1A2 (rs2069514 and rs762551) Polymorphisms in COVID-19 Patients
por: Bozkurt, I, et al.
Publicado: (2023)

CYP19 Genetic Polymorphism Haplotype AASA Is Associated with a Poor Prognosis in Premenopausal Women with Lymph Node-Negative, Hormone Receptor-Positive Breast Cancer
por: Kuo, Sung-Hsin, et al.
Publicado: (2013)

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
por: Simonsson, Maria, et al.
Publicado: (2016)

Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor?Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
por: Suh, Koung Jin, et al.
Publicado: (2017)

Delineating the role of single-nucleotide polymorphism of CYP19 gene on aromatase activity in South Indian women with polycystic ovary syndrome
por: Hegde, Pravesh, et al.
Publicado: (2023)

Successful treatment of low-grade endometrial cancer in premenopausal women with an aromatase inhibitor after failure with oral or intrauterine progesterone
por: Straubhar, Alli, et al.
Publicado: (2017)

Association Study of Aromatase Gene (CYP19A1) in Essential Hypertension
por: Shimodaira, Masanori, et al.
Publicado: (2008)

Polymorphisms, endogenous hormone levels and familial breast cancer risk in premenopausal women
por: Walker, K, et al.
Publicado: (2010)

SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study
por: Reimer, Toralf, et al.
Publicado: (2016)

The CYP19 RS4646 Polymorphism IS Related to the Prognosis of Stage I–II and Operable Stage III Breast Cancer
por: Shao, Xiying, et al.
Publicado: (2015)

No associations between aromatase gene polymorphisms and breast cancer risk in Saudi patients
por: Alanazi, Mohammed, et al.
Publicado: (2015)

Association among VKORC1 rs9923231, CYP4F2 rs2108622, GGCX rs11676382 polymorphisms and acute ischemic stroke
por: Iluţ, Silvina, et al.
Publicado: (2023)

Associations between CYP2C8 rs10509681 and rs11572080 gene polymorphisms and age-related macular degeneration
por: Liutkevičienė, Rasa, et al.
Publicado: (2017)

Investigating the CYP2B6 rs3745274 and rs3211371 Polymorphisms in Methadone-Responder and Non-Responder Addicts in Iran
por: Aghabozorg Afjeh, Sara Sadat, et al.
Publicado: (2021)

ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease
por: Siokas, Vasileios, et al.
Publicado: (2021)

Cyp19a1 (Aromatase) Expression in the Xenopus Brain at Different Developmental Stages
por: Coumailleau, P, et al.
Publicado: (2014)

Aromatase Deficiency due to a Novel Mutation in CYP19A1 Gene
por: Unal, Edip, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_np8ks59ks5kcjtv2h198v8f3gb